Avanir and Vital Therapies propose follow-ons

Vital Therapies Inc. (NASDAQ:VTL) said in an SEC filing on Monday that it plans to raise $46 million in a follow-on underwritten by BofA Merrill Lynch; William Blair; Canaccord Genuity; and SunTrust Robinson Humphrey. Vital closed down $1.84 to $18.27 on the day. ...